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ABSTRACT
The upstream binding factor UBF, an activator of
RNApolymeraseItranscription,isposttranslationally
modified by phosphorylation and acetylation. We
found that in NIH3T3 cells, UBF is acetylated in
S-phase but not in G1-phase. To assess the role of
acetylation in regulation of UBF activity, we have
established an NIH3T3 cell line that inducibly over-
expresses HDAC1. Both in vivo and in vitro, HDAC1
efficiently hypoacetylates UBF. Immunoprecipita-
tion with antibodies against the Pol I-associated
factor PAF53 co-precipitated UBF in mock cells
but not in cells overexpressing HDAC1. Pull-down
experiments showed that acetylation of UBF
augments the interaction with Pol I. Consistent with
acetylation of UBF being important for association of
PAF53 and recruitment of Pol I, the level of Pol I
associated with rDNA and pre-rRNA synthesis
were reduced in cells overexpressing HDAC1. The
results suggest that acetylation and deacetylation
of UBF regulate rRNA synthesis during cell cycle
progression.
INTRODUCTION
Cells contain multiple copies of the genes encoding ribosomal
RNA, ranging from several hundred in most mammals to
several thousand copies in some plants. Roughly 50% of a
cell’s transcriptional activity is due to the synthesis of rRNA
(1,2). About half of the rRNA genes are active, while the other
half is silent. There is increasing evidence that rRNA synthesis
is regulated by varying the transcription rate of potentially
active genes rather than by varying the ratio of active to
inactive genes (3,4). As changes in rDNA transcription affect
cell growth and proliferation, rDNA transcription has to be
stringently regulated in response to divergent conditions,
ranging from high proliferation rates to conditions of restricted
growth under nutrient depletion, from early embryonic devel-
opment to stages of cellular senescence (5,6). Moreover,
rDNA transcription in mammalian cells ﬂuctuates during
the cell cycle, being low in early G1-phase, reaching highest
levels in S- and G2-phase, and being shut off in mitosis (5,7).
Importantregulatorsofproliferation,suchasthec-mycprotein
and the tumour suppressors pRb and p53, control the readout
of rRNA genes (5,8).
One of the key components of the RNA polymerase I
transcription initiation complex is the upstream binding factor
UBF, whose activity is regulated by posttranslational modiﬁ-
cations. In growing cells, UBF is phosphorylated at multiple
sites, and phosphorylation regulates its interaction with SL1
and enhances the association of UBF with Pol I (9,10). In
quiescent cells, on the other hand, UBF is hypophosphorylated
and transcriptionally inactive (11,12). In addition to phospho-
rylation, acetylation of UBF plays an important role in the
control of rDNA transcription (13,14). Acetylation and
deacetylation regulate UBF activity without affecting its
DNA binding properties. CBP-dependent acetylation of
UBF has been shown to facilitate transcription activation,
in part by counteracting the repressive effect of the tumour
suppressors pRb and p130 (15–19). A ‘ﬂip-ﬂop’ model has
been suggested for the regulation of rDNA transcription
through acetylation of UBF by CBP and deacetylation by
HDAC (14). According to this model, association with and
acetylation by CBP activates Pol I transcription. Excess
pRb prevents the formation of the UBF–CBP complex
and, by recruiting HDAC, catalyzes UBF deacetylation
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doi:10.1093/nar/gkl101and Pol I inactivation. Though this is an attractive model, the
mechanism by which UBF acetylation affects Pol I
transcription remains unknown.
To elucidate the effect of acetylation and deacetylation of
UBF on RNA polymerase I recruitment and rDNA transcrip-
tion, we generated a cell line that overexpresses ﬂag-tagged
HDAC1 under the control of an inducible promoter. Using
this cell line, we demonstrate that UBF is deacetylated upon
induction of HDAC1, whereas pRb remains acetylated.
Deacetylated UBF does not interact with PAF53, a subunit
of Pol I, suggesting that acetylation of UBF promotes
the association of Pol I with the rDNA promoter. As a
consequence, the assembly of productive Pol I transcription
complexes is impaired, leading to a decrease in pre-rRNA
synthesis. The ﬁnding that association of acetylated
UBF and PAF53 in NIH3T3 cells occurs exclusively
during S- and G2-phase underscores the importance of UBF
acetylation for cell cycle-dependent regulation of rRNA
synthesis.
MATERIALS AND METHODS
Cell culture and synchronization
NIH3T3 cells (DSMZ ACC59) were cultivated in DMEM/
Ham0s F12-K medium supplemented with 10% fetal
calf serum (FCS), 2 mM L-glutamine and 0.1 mg/ml
penicillin-streptomycin. Cell cycle durations of exponentially
growing cells were wild type, 15.5 h; HDAC1-ﬂag (clone 1D),
22.5 h; mock control, 21.7 h. For synchronization cells
were grown in medium with 0.5% FCS for 48 h and
induced for proliferation by adding of fresh medium
containing 10% FCS. Cell cycle-speciﬁc stages were obtained
by harvesting cells at 0 h (G0), 10 h (G1), 16 h (S) and 20 h
(G2), respectively.
Transfection of cells
To generate a cell line that expresses HDAC1 under the con-
trol of the lac promoter, NIH3T3 cells were transfected with
pCMVLacI  (LacSwitch  II Inducible Mammalian Expres-
sion System; Stratagene) using Polyfect (Quiagen) according
to the manufacturer0s instructions. After selection with
hygromycin one clone was used for transfection with either
mock (ﬂag sequence)- or mHDAC1-ﬂag-pOPRSVI/MCS
expression vector (Stratagene). Individual cell clones were
analysed for HDAC expression in the presence of 5 mM
isopropyl-b-D-thiogalactopyranoside (IPTG). Unless other-
wise stated, our data refer to the mock- and 3T3-clone 1D
after 24 h of IPTG induction.
Antibodies
Antibodies were purchased from the following sources.
Anti-ﬂag  M2 from Sigma; anti-HDAC1, rabbit polyclonal
antibody from Zymed; anti-acetyl-lysine and anti-acetyl-
histone H4, rabbit polyclonal antibodies from Upstate;
anti-UBF and anti-pRb, rabbit polyclonal antibodies from
Santa Cruz Biotechnology. Rabbit polyclonal antibodies
against the Pol I subunits PAF53 and RPA116 have been
described elsewhere (20).
Immunoprecipitation assays
Samples (100 ml) (equivalent to 200 mg of total protein) were
incubated at 4 C overnight with either 5 mg/ml antibody
(30 min at 4 C) before binding to 30 ml of protein
A–Sepharose or with 30 ml of equilibrated anti-ﬂag  M2
agarose (Sigma). After centrifugation (1000 g for 5 min)
the pellets were washed with 40 vol of buffer E [10 mM
Tris–HCl, pH 7.5, 100 mM KCl, 1.5 mM MgCl2, 10%
(v/v) glycerol], and proteins were analysed on western blots.
Pull-down experiments
Recombinant ﬂag-UBF from insect cells was immunoprecipi-
tated with anti-ﬂag  M2 agarose at 4 C overnight. [
14C]acety-
lated or non-acetylated ﬂag-UBF beads (30 ml) were incubated
withnuclearextracts (100ml)inthepresenceof0.1mMTSAat
4 C overnight, washed with 40 vol buffer E and analysed on
western blots.
Immunofluorescence
Cells grown on cover slips were ﬁxed with 1% (v/v) formalde-
hyde in phosphate-buffered saline (PBS) at 4 C for 15 min,
rinsed with PBS and permeabilized in 80% (v/v) ethanol for
4ha t4  C and 0.25% (w/v) Triton X-100 in PBS at 4 C
for 5 min and incubated with antibodies at room temperature
for 2 h. Slips were incubated with FITC- or TRIC-conjugated
secondary antibody (diluted 1:40; DAKO) at room tempera-
ture for 2 h and visualized in a Zeiss Axioplan ﬂuorescence
microscope with a photoimaging appliance.
Preparation of nuclear and nucleolar extracts
Nuclear extracts were prepared using the NE-PER  Nuclear
and Cytoplasmic Extraction kit (Pierce). For chromatographic
separation, extracts were prepared in a different way. The cell
pellet was washed with PBS and suspended in NI buffer [0.1%
(w/v) sodium citrate, 0.1% (w/v) Triton X-100, pH 7.4]. The
suspension was incubated for 10 min and disruption of cells
was obtained by vortexing; cell disruption was checked by
microscopy. Isolatednuclei werewashed with PBS,suspended
in extraction buffer [10 mM Tris–HCl, pH 7.8, 200 mM
NaCl, 1.5 mM MgCl2, 0.5% (v/v) NP-40, supplemented
with protease inhibitor cocktail (Roche)] and extracted
under shaking for 90 min. After centrifugation at 12000 g
for 15 min the supernatant was taken as the nuclear extract.
Nucleoli were isolated as described elsewhere (21) with
modiﬁcations. Isolated nuclei, suspended in 5 ml of 0.25 M
sucrose, were centrifuged through 5 ml of 0.88 M sucrose at
1650 g for 10 min at 4 C, washed with 5 ml of 0.34 M sucrose
(+0.1 mM phenylmethlysulfonyl ﬂuoride) andsonicated on ice
with 15 pulses (cycle 0.5, amplitude 40; UP200; Hilscher
GmbH). Disruption of nuclei was checked by microscopy
and staining. Nucleoli were puriﬁed by centrifugation through
a cushion of 0.88 M sucrose at 2200 g for 20 min. Nucleoli
were washed with PBS, suspended in extraction buffer
[10 mM Tris–HCl, pH 7.8, 300 mM NaCl, 1.5 mM MgCl2,
0.075% (w/v) NP-40, supplemented with protease inhibitor
cocktail (Roche)] and incubated under shaking for 90 min.
After centrifugation at 12000 g for 15 min the supernatant
was taken as the nucleolar extract. For some experiments, pure
nucleoli were directly suspended in Laemmli Sample Buffer
without extraction.
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For in vitro acetylation, recombinant ﬂag-UBF from insect
cells was immobilized on M2 agarose and 50 ml ﬂag-UBF
beads were equilibrated in buffer E (supplemented with
0.1 mM TSA, 0.1 mM EDTA, 1 mM DTT and protease
inhibitor cocktail), suspended in a ﬁnal volume of 150 ml
and mixed with 30 ml of recombinant acetyltransferase
p300-His (0.1 mg/ml) and 10 mlo f[
14C]acetyl-CoA
(57 mCi/mmol, 50 mCi/ml; Amersham Biosciences). Reaction
mixtures were incubated at 30 C for 2 h.
14C-acetyl-labelled
ﬂag-UBF beads were washed with 50 vol of buffer E and used
for FDAC-assays or pulldown experiments.
For autoradiography,
14C-acetyl-labelled ﬂag-UBF beads
were centrifuged at 1000 g for 5 min, mixed with an equal
vol of 2· Laemmli sample buffer and heated to 95 C for
5 min. After centrifugation, the supernatant was subjected
to SDS–PAGE. Gels were dried, exposed on phosphoimager
screens and analysed on a STORM 840 (Molecular
Dynamics).
Deacetylase assay
HDAC- or FDAC-activities were determined as described (22)
using [
3H]acetate prelabelled chicken reticulocyte histones or
[
14C]acetateprelabelledﬂag-UBFbeads.Samples(50ml)were
mixed with 10 ml prelabelled core histones (40 mg) or 30 mlo f
14C-prelabelled ﬂag-UBF (4 mg) and incubated at 37 C for 2 h.
The reaction was stopped by addition of 1 M HCl/0.4 M
acetate and ethylacetate. After centrifugation aliquots of the
upper phase were counted for radioactivity.
Gel filtration chromatography
Nuclear extracts were subjected to gel ﬁltration chromato-
graphy, using a Tosoh TSK-G4000 PWXL column (Tosoh
Biosep). The column was equilibrated [10 mM Tris–HCl,
pH 7.8, 100 mM NaCl, 0.5 mM EDTA, 10% (v/v) glycerol],
the ﬂow rate was maintained at 0.4 ml/min, and fractions of
400 ml were collected.
RESULTS
Characterization of a cell line that overexpresses
HDAC1 under the control of an inducible promoter
We have established an NIH3T3 cell line that expresses
ﬂag-tagged HDAC1 under the control of an IPTG-inducible
lac promoter placed upstream of an RSV-promoter. After
extensive characterization of different clones, one clone
(termed 3T3-clone 1D) and a corresponding mock clone
were chosen for the subsequent experiments. Unless otherwise
stated, our data were derived from the mock- and the
3T3-clone 1D, respectively, 24 h after induction of HDAC1
expression by IPTG induction.
Overexpression of ﬂag-tagged HDAC1 caused a signiﬁcant
increase of total HDAC activity in 3T3-clone 1D, being  50%
higher compared to uninduced cells (Figure 1A, upper panel).
In contrast, HDAC-activity did not change in mock-
transfected cells upon IPTG treatment. The increase in
HDAC activity correlated with an increase in HDAC1
mRNA levels measured by semi-quantitative RT–PCR (data
not shown). As expected, an anti-ﬂag antibody detected
HDAC1-ﬂag in 3T3-clone 1D at 24 and 48 h but not in the
mock cell line; a corresponding result was obtained with an
anti-HDAC1 antibody (Figure 1A, lower panel). Densitomet-
ric evaluation of immunoblots revealed that the amount of
overexpressed HDAC1-ﬂag was 22% of the endogenous
HDAC1 at 24 h after induction and 37% at 48 h.
To test whether HDAC1 overexpression would reduce the
global acetylation level of core histones, we compared
the extent of histone H4 acetylation in nuclei and nucleoli.
The immunoblot in Figure 1B shows that the acetylation level
ofhistoneH4wasslightlyreduced innuclearlysatesfromcells
overexpressing HDAC1 compared with control cells (left
panel). This effect was more pronounced in lysates of isolated
nucleoli (right panel). Densitometric evaluation revealed that
acetylation of histone H4 was decreased by 14% in nuclear
lysates and by 26% in nucleolar lysates.
To test whether recombinant HDAC1-ﬂag has a correct
physiological localization we performed immunoﬂuorescence
microscopy with anti-ﬂag antibodies. Recombinant HDAC1
was localized in the nuclei of HDAC1-overexpressing cells,
while mock cells exhibited negligible background staining
(Figure 1C). Immunoﬂuorescence analysis of HDAC1-ﬂag
and the nucleolar marker UBF at higher magniﬁcation
revealed that HDAC1-ﬂag not only localized to nuclei but
was also present in the nucleoli (Figure 1D).
These results show that upon IPTG induction enzymatically
active HDAC1-ﬂag is expressed which is correctly located in
the nucleus and deacetylates histones.
UBF is hypoacetylated in cells overexpressing HDAC1
When nuclear extracts from 3T3-clone 1D and mock cells
were size-fractionated by gel ﬁltration, HDAC activity eluted
in two peaks, a main fraction of  800 kDa and a minor one of
 1.3 MDa (Figure 2A). Flag-tagged HDAC1 was present in
both peaks, albeit with higher abundance in the 1.3 MDa
fractions (data not shown). Two lines of evidence suggest
that overexpressed HDAC1-ﬂag was assembled into physio-
logically relevant protein complexes. First, NIH3T3 cells
displayed an identical distribution of HDAC activity after
gel ﬁltration chromatography, and second 3T3-clone 1D
showed a 20% higher HDAC activity in the 1.3 MDa peak
compared with the mock control.
Western blot analysis of individual fractions from the gel
ﬁltration column (Figure 2A) with anti-UBF antibodies
showed that the 1.3 MDa complex (fraction 15) contains
UBF (Figure 2B, upper panel). Signiﬁcantly, immunoblotting
with anti-acetyl-lysine antibodies indicated that UBF is acety-
lated in control cells but not in 3T3-clone 1D (Figure 2B,
centre panel). Fraction 15 also contained pRb (Figure 2B,
centre and lower panel; marked by asterisk) that was acety-
lated both inmock control cells and 3T3-clone 1D.Theﬁnding
that UBF, but not pRb is hypoacetylated in 3T3-clone
1D indicates that the HDAC1 complex displays a distinct
substrate speciﬁcity.
To further prove that UBF is deacetylated in
HDAC1-overexpressing cells we incubated fraction 15 of
the gel ﬁltration column (Figure 2A) with anti-acetyl-lysine
antibodies and monitored precipitation of UBF and pRb on
immunoblots (Figure 2C). Clearly, anti-acetyl-lysine antibod-
ies precipitated UBF from mock cells, but not from 3T3-clone
1800 Nucleic Acids Research, 2006, Vol. 34, No. 61D (left panel). In contrast, anti-acetyl-lysine antibodies
precipitated pRb both in mock and 3T3-clone 1D (centre
panel, marked by asterisk; right panel). Thus, overexpressed
HDAC1 speciﬁcally deacetylates UBF in the 1.3 MDa
complex.
As UBF is an essential Pol I transcription factor, we
examined the level of UBF acetylation in extracts from
isolated nucleoli. While the amount of UBF was similar in
mock cells and 3T3-clone 1D (Figure 2D), anti-acetyl-lysine
antibodies precipitated signiﬁcant amounts of UBF from
nucleolar extracts of mock cells, whereas practically no
UBF was precipitated from 3T3-clone 1D (Figure 2D). This
indicates that UBF is acetylated in nucleoli of mock cells and
is deacetylated upon induction of HDAC1.
In vitro acetylation and deacetylation of UBF
To investigate the functional signiﬁcance of UBF acetylation,
we expressed ﬂag-tagged murine UBF in insect cells and
monitored acetylation with anti-acetyl-lysine antibodies. As
shown in Figure 3A, the acetylation level of UBF expressed in
Sf9 cells is very low (Figure 3A, lane 3). However, recombi-
nant UBF was efﬁciently acetylated in vitro after incubation
with [
14C]acetyl-CoA and recombinant acetyltransferase
p300, as revealed by measuring incorporated radioactivity,
autoradiography and immunoblotting with anti-acetyl-lysine
antibodies (Figure 3B).
Next, we used in vitro labelled UBF as a substrate to assay
deacetylase activity. Fraction 15 from the TSK gel ﬁltration
column (Figure 2A) containing the 1.3 MDa HDAC1-activity
peak deacetylated  10% of UBF and  30% of core histones
compared to input levels (Figure 3C). A similar result was
obtained with puriﬁed recombinant HDAC1, demonstrating
that UBF is deacetylated by HDAC1 in vitro.
Acetylation modulates the interaction of UBF with
Pol I and transcription complex formation
To investigate the functional consequences of UBF deacety-
lation, we examined the ability of acetylated and deacetylated
UBF to interactwith the PolI transcription apparatus. UBF has
been shown to interact with PAF53, a 53 kDa protein that is
tightly associated with Pol I (23). Western blot analysis
showed that the 1.3 MDa fraction of the gel ﬁltration column
Figure 1. Characterization of a stably transfected NIH3T3 cell line overex-
pressing HDAC1 under the control of an inducible promoter. (A) HDAC
activity (upper panel) and expression of HDAC1-flag protein (lower panels)
in mock cells and 3T3-clone 1D after IPTG induction. HDAC activity was
measured by the standard assay with chicken reticulocyte core histones as
substrate. Enzyme activity is expressed as percentage of the uninduced cell
line. Error bars indicate the SD from the mean of three independent experi-
ments.Productionofrecombinantflag-taggedHDAC1proteinwasdetermined
by immunoblotting with anti-flag antibodies. Total HDAC1 (endogenous
HDAC1 and recombinant flag-tagged HDAC1) was detected by immuno-
blotting with anti-HDAC1 antibodies; 30 mg of total protein were applied to
eachlane. (B) AcetylationofhistoneH4in mockcells and3T3-clone1D. Bulk
histone H4 acetylation was determined in lysates of nuclei (left panels; 25 mg
totalproteinperlane)andnucleoli(rightpanels;20mgtotalproteinperlane)of
IPTG induced mock- and HDAC1-overexpressing cells by immunoblotting
with an anti-acetyl-H4 antibody. Alkaline phosphatase conjugated secondary
antibodies were used for visualization of immunosignals (upper panels). The
corresponding Coomassie stained gels are provided as loading control (lower
panels). (C) Subcellular localization of overexpressed flag-tagged HDAC1.
Exponentiallygrowingmock-andHDAC1-overexpressingcellswereanalysed
by phase contrast (upper panels) and immunofluorescence microscopy (lower
panels) with anti-flag antibodies. Magnification, 400·.( D) Subnuclear
localization of overexpressed flag-tagged HDAC1 and UBF. Exponentially
growing mock- and HDAC1-overexpressing cells were analysed by immuno-
fluoresence microscopy with anti-UBF antibodies (green fluorescence) and
anti-flag antibodies (red fluorescence). Magnification, 1000·.
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anti-PAF53 antibodies were used to precipitate Pol I from
this fraction, UBF was co-precipitated from mock-transfected
cells but not from 3T3-clone 1D (Figure 4A). Similar amounts
of RPA116, the second largest subunit of Pol I, were
co-precipitated in both mock cells and 3T3-clone 1D, suggest-
ing that deacetylation of UBF by HDAC1 impairs the
interaction of UBF with Pol I.
TotestwhetheracetylationofUBFaugmentsthe interaction
with Pol I, pull-down assays were performed using bead-
bound in vitro acetylated ﬂag-UBF and nuclear extracts in
the presence of Trichostatin A (Figure 4B; [
14C] panel).
Trichostatin was added to prevent deacetylation during the
incubation time. Analysis of captured proteins by
immunoblotting revealed that acetylated UBF retained
PAF53, while non-acetylated UBF did not interact with
PAF53 (Figure 4B). Likewise, RPA116 was only retained
by acetylated UBF, suggesting that acetylation is a major
determinant for the association of UBF with Pol I. In addition,
the pull-down experiments show that endogenous HDAC1 is
more efﬁciently retained by acetylated UBF, consistent with
acetylation facilitating the interaction of UBF and Pol I
(Figure 4B).
To test whether UBF acetylation modulates the nucleolar
retention of UBF or Pol I, we compared the amount of UBF
and Pol I in nucleoli isolated from 3T3-clone 1D and mock
cells. For this purpose, cells were synchronized in G1- and
S-phase, as initial experiments have shown that the effect of
HDAC1 on rRNA synthesis was most pronounced in S-phase.
In G1-phase, i.e. 10 h after release from serum starvation, no
signiﬁcant differences in the level of UBF and Pol I were
observed in nucleoli of 3T3-clone 1D and mock cells
(Figure 4C). However, in S-phase (16 h after refeeding),
the level of RPA116 and PAF53 that was retained in nucleoli
was considerably lower in 3T3-clone 1D than in the mock
control. The amount of UBF, on the other hand, remained
unchanged (Figure 4C). The amount of total cellular PAF53
and RPA116 was equal (data not shown). Thus, overexpres-
sionofHDAC1eitherimpairstherecruitment ofPolItorDNA
or weakens the association of Pol I with nucleolar structures.
Given that the amount of Pol I that is associated with rDNA
reﬂects cellular pre-rRNA synthetic activity, the level of 45S
pre-rRNA should be lower in S-phase cells overexpressing
HDAC1 than in G1-phase cells or mock control. Indeed, the
decrease of PAF53 and RPA116 levels in 3T3-clone 1D in
S-phasewasaccompaniedbyapronounced reduction ofrDNA
transcription (Figure 4C, pre-rRNA panel), supporting the
view that HDAC1-mediated deacetylation of UBF abrogates
Pol I transcription.
To verify that acetylation regulates the interaction of UBF
and Pol I, we analysed the interaction of these proteins in
cells that do not overexpress HDAC1. Nucleolar extracts
Figure 2. Hypoacetylation of UBF in HDAC1-overexpressing NIH3T3 cells
during S-phase. Nuclear extracts of mock and 3T3-clone 1D in S-phase were
subjected to TSK gel filtration chromatography. Chromatographic fractions
(ranging from 0.2 to 1.6 MDa) were analysed by HDAC activity assay (A),
immunoblotting (B) and immunoprecipitation (C). (A) HDAC activity of
nuclear extracts after TSK gel filtration chromatography. Fractions were
assayed for histone deacetylase activity which was expressed as percentage
of the maximum activity (open circles, mock-transfected cells; closed squares,
HDAC1-overexpressing cells). (B) Immunoblot analysis. Fractions 13–25 of
the TSK chromatography (mock control and 3T3-clone 1D) were subjected to
SDS–PAGE with subsequent immunoblotting using anti-UBF antibodies
(upper panel), anti-acetyl-lysine antibodies (centre panel), and anti-pRb
antibodies (lower panel). Arrows mark the position of UBF, asterisks mark
the position of the retinoblastoma protein (pRb). (C) Immunoprecipitation of
acetylated UBF. TSK fractions 15 of the mock control and 3T3-clone 1D,
respectively, were subjected to immunoprecipitation with anti-acetyl-lysine
antibodies. Immunoprecipitated proteins were subjected to SDS–PAGE and
western blotting. Proteins were immunodetected with antibodies against UBF
(left panel), acetyl-lysine (centre panel) and pRb (right panel). An arrow
indicates the position of UBF, an asterisk marks the position of the retinoblas-
tomaprotein.(D)ImmunoprecipitationofacetylatedUBFinnucleolarextracts.
Nucleolarextractsofmockcontroland3T3-clone1DinS-phaseweresubjected
to immunoprecipitation with anti-acetyl-lysine antibodies. Input extracts (left
panel, input) and immunoprecipitates (right panel; IP) were subjected to
immunoblotting using anti-UBF antibodies for detection.
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G1-phase (10 h), S-phase (16 h) and G2-phase (20 h) were
incubated with antibodies against PAF53 and
co-immunoprecipitated UBF was analysed on western blots.
As shown in Figure 5A, PAF53 did not interact with UBF in
G0- and G1-phase cells, whereas signiﬁcant amounts of UBF
co-precipitated with Pol I from S- and G2-phase extracts. The
coprecipitation at 16 and 20 h can not be attributed to
the moderate increase in UBF input from 0 to 16 h, since
absolutely no coprecipitation of UBF takes place at 0 and
10 h. In contrast, anti-PAF53 antibodies co-precipitated
RPA116 irrespective of the cell cycle stage (Figure 5A),
indicating that PAF53 is rather associated with Pol I during
the whole cell cycle. Noteworthy, co-precipitated UBF from
S-phase cells (16 and 20 h) was acetylated, consistent with
UBF acetylation enhancing the interaction with Pol I. In sup-
port of this, anti-acetyl-lysine antibodies immunoprecipitated
signiﬁcant amounts of UBF from S-phase nucleolar extracts,
but not from G0-phase extracts (Figure 5B). Densitometric
analysis reveals that the overall amount of nucleolar UBF
increased 1.5-fold during the transition from G1- to S-phase
(0–16 h, input panel), whereas the amount of UBF that
precipitated with anti-acetyl-lysine antibodies (IP panel)
increased  5-fold (densitometry not shown in ﬁgure).
These results suggest that cell cycle-dependent changes of
UBF acetylation are involved in the regulation of Pol I
transcription.
DISCUSSION
In eukaryotes, transcription of ribosomal RNA represents
>50% of total RNA synthetic activity and is tightly regulated
according to the cell’s biosynthetic demand for ribosomes.
Numerous studies have established that almost every compo-
nent of the Pol I transcription apparatus is targeted by the
complex regulatory network that controls pre-rRNA synthesis
(5). One of the targets that regulate Pol I transcription is UBF.
UBF was shown tobindacrossthe entire rDNArepeat,thereby
leading to enrichment of the Pol I transcription machinery
Figure 3. Acetylation and deacetylation of UBF. Recombinant flag-tagged UBF was expressed in insect cells, acetylated in vitro by recombinant acetyltransferase
p300 and subsequently deacetylated by HDAC1. (A) Expression of recombinant UBF in insect cells. Flag-UBF was affinity purified by anti-flag-agarose elution.
Lane 1, SDS–polyacrylamide gel (Comassie stained) of affinity-purified flag-UBF; lane 2, immunoblot with anti-flag antibodies; lane 3, immunoblot with
anti-acetyl-lysine antibodies. (B) Acetylation of UBF by p300. Affinity-purified flag-UBF was acetylated in vitro by recombinant p300 and [
14C]acetyl-CoA.
Acetyltransferase activity is expressed as radioactivity incorporation in cpm (upper part). Aliquots of the acetyltransferase assay (different composition shown in
diagram table) were subjected to SDS–PAGE (Coomassie stain; upper panel) with subsequent autoradiography (
14C; centre panel) or immunoblotting with
anti-acetyl-lysine antibodies (lower panel). (C) Deacetylation of UBF by HDAC1. [
14C]acetyl labelled flag-UBF was used as a substrate for deacetylase assays
usingfraction15(50ml)ofTSKgelfiltrationchromatography(Figure2A)from3T3-clone1Doraffinitypurifiedflag-taggedHDAC1(0.2mg)from3T3-clone1Das
enzymesource.DeacetylaseactivitywithacetylatedUBF(4mg)assubstrate(closedcolumns).Asareference,enzymepreparationswereincubatedwithprelabelled
chicken reticulocyte core histones (40 mg; open columns). Deacetylase activities are expressed as percent of the corresponding input radioactivity.
Nucleic Acids Research, 2006, Vol. 34, No. 6 1803(24). Binding of UBF to the upstream control element is a
crucial step in the formation of the Pol I pre-initiation
complex. UBF interacts with both Pol I (25) and the
TBP-containing promoter selectivity factor SL-1/TIF-1B
(26), thereby targeting the Pol I transcription machinery to
rDNA and facilitating the assembly of transcription initiation
complexes. UBF function is impaired through interacting
proteins, such as pRb (15,19), p130 (16) and p53 (18,27).
Moreover, UBF activity is modulated by phosphorylation at
multiple sites by cyclinD1/CDK4 (28) and cyclinE/CDK2
(10), casein kinase II (9), ERK1/2 MAP-kinase (29), and
the p70S6-kinase (30). In addition, UBF has been shown
to be acetylated (14), but the functional signiﬁcance of this
modiﬁcation remained elusive.
During the last decade it became evident that HATs and
HDACs not only modify histones but also non-histone
proteins, such as pRb, c-myc and p53 (31–33). In practically
all cases of non-histone protein acetylation the modiﬁcation
causes changes of the interaction properties of the protein or
stabilization of protein complexes. For example, acetylation of
p53 by CBP and p300, but not by PCAF, stabilizes p53
complexes, whereas deacetylation is required for its efﬁcient
degradation (34). Another example is TFIIB which has to be
acetylated to interact with TFIIF, thereby activating RNA
polymerase II transcription (35).
Since active ribosomal genes are characterized by a lack of
intact nucleosomes (3), the inhibitory effect of HDAC1 on
transcription of ribosomal genes cannot be exclusively due
to a decrease of histone acetylation but also has tobe attributed
to deacetylation of components of the Pol I transcription
machinery.ThesameistruefortheeffectsofHDACinhibitors
on Pol I transcription (13). Furthermore, some of the proteins
involved in the regulation of ribosomal gene transcription (e.g.
pRb, c-myc and p53) (31–33) are reversibly acetylated.
Regulation of Pol I transcription through competitive
recruitment of CBP and HDAC to rDNA, as well as the effect
of acetylation upon rDNA transcription has been described
recently (13,14,36). These studies have demonstrated that
acetylation activates rDNA transcription both by acetylation
of histone tails and by recruitment of the Pol I transcription
apparatus to the rDNA promoter. UBF is efﬁciently acetylated
by CBP and Tip60, both of which have been shown to stimu-
late rDNA transcription in a nucleosome-independent manner.
Most likely, Tip60 is the responsible acetyltransferase in vivo
(36), whereas the responsible HDAC had not been identiﬁed.
Fractionation of nuclear extracts by gel ﬁltration
chromatography has shown that acetylated UBF is part of a
1.3 MDa protein complex which contains other components of
the Pol I transcription machinery, and very likely corresponds
to a Pol I ‘holoenzyme’. The 1.3 MDa complex contains
Figure 4. Deacetylation of UBF by HDAC1 inhibitsthe associationwith PolI.
(A) Co-immunoprecipitation of UBF with Pol I. Extracts from mock- and
HDAC1-overexpressing cells were fractionated by gel filtration as shown in
Figure2.TheamountofPAF53,RPA116andUBFpresentin20mgofproteinin
chromatographic fractions 15 was monitored on immunoblots (input, left
panel). Samples were incubated with anti-PAF53 antibodies and the immuno-
precipitates were analyzed with antibodies against UBF and RPA116 (centre
panel;a-PAF53IP).Tocheckfortheefficiencyoftheprecipitationreactionthe
supernatant was immunoblotted with anti-PAF53 antibodies (SN, right panel).
(B) PAF53 does not interact with non-acetylated UBF. Nuclear extracts of
NIH3T3cellsinS-phasewereincubatedwith5mgimmobilized,non-acetylated
or [
14C]acetylated flag-UBF in the presence of 0.1 mM trichostatin A. Bound
proteins were analysed on immunoblots with antibodies against PAF53,





non-acetylated and acetylated immobilized flag-UBF (dilution 1:5). (C)
Amount of UBF, RPA116 and PAF53 in nucleoli 10 and 16 h after refeeding
of serum-starved cells. Nucleoli were isolated from mock cells and 3T3-clone
1D cells at 10 h (G1-phase, left panels) and 16 h (S-phase, right panels) after
refeeding. Nucleolar lysates were analysed by SDS–PAGE with subsequent
immunoblottingwithantibodiesagainstUBF,RPA116andPAF53.Inparallel,
cellular RNA was isolated and pre-rRNA levels in the same number of cells
(10 ml) was determined on northern blots using a digitonin-labelled probe
against the 50-terminal 150 bases of the primary transcript.
1804 Nucleic Acids Research, 2006, Vol. 34, No. 6HDAC1 and pull-down experiments have shown that acety-
lated UBF retains HDAC1 whereas non-acetylated UBF does
not. We analyzed the increased association of HDAC1 to
acetylated ﬂag-UBF in the presence and absence of the
deacetylase inhibitor trichostatin A (data not shown). Regard-
less of whether trichostatin was present or not, we observed a
signiﬁcantly increased binding of HDAC1 to acetylated
ﬂag-UBF at 4 C; this rather suggests that the association of
HDAC1 with acetylated UBF is not due to the direct catalytic
interaction of enzyme and substrate, but is due to speciﬁc
protein-protein interactions, maybe mediated by an interacting
protein (e.g. pRb).
In HDAC1-overexpressing cells UBF is deacetylated and
pre-rRNA synthesis is down-regulated. The effect of UBF
acetylation was most pronounced in S-phase, indicating that
reversible acetylation of UBF may be a means to modulate
pre-rRNA synthesis during cell cycle progression.
Importantly, our results elucidate the mechanism under-
lying activation of Pol I transcription by UBF acetylation.
Acetylation stimulates the interaction with PAF53, a subunit
of the initiation-competent subpopulation of Pol I. The need
for such a regulated recruitment becomes more evident, if
one considers that yeast contains a 17-fold excess of Pol I
compared with the rDNA binding factors UAF and CF (37).
The following observations suggest that reversible
UBF acetylation regulates the interaction with PAF53 and
thus the recruitment of Pol I to rDNA. First, acetylation of
UBF occurs within HMG boxes 1 and 2 (14), the part of UBF
that is required for interaction with Pol I (25). Second, over-
expression of HDAC1 did not affect the nucleolar localization
of UBF, whereas the nucleolar retention of Pol I was strongly
decreased. Like the inhibition of Pol I transcription in
HDAC1-overexpressing cells, the decrease of Pol I within
the nucleolus was most evident in S-phase. This suggests
that the interaction between acetylated UBF and PAF53
is important to recruit Pol I, together with associated
factors, to the rDNA promoter and facilitates transcription
initiation.
With regard to the mechanism by which acetylation
regulates UBF function, it is conceivable that acetylation
induces a structural change which may be required for the
interaction of UBF with Pol I. In support of this, we found
that different antibodies against UBF precipitated UBF in its
deacetylatedform,butfailedtoprecipitateacetylatedUBF.On
immunoblots, however, all antibodies recognized both acety-
lated and deacetylated UBF with equal efﬁciency. It is also
likely that UBF acetylation and phosphorylation are interre-
lated, both ﬂuctuating during cell cycle progression (10,28).
Acetylation assays with mutant UBF revealed that replace-
ment of serine 388 by alanine resulted in signiﬁcantly
enhanced p300-mediated in vitro acetylation, whereas muta-
tion of serine 484 resulted in a complete inhibition of acety-
lation by p300 in vitro (J. Meraner and P. Loidl, unpublished
data). These data strongly argue for a speciﬁc and physiolo-
gically relevant interdependence of acetylation and
phosphorylation events, similar to those described for the
retinoblastoma protein (31). Finally, acetylation of TFIIB is
necessary for a strong interaction with TFIIF, thereby activat-
ing RNA polymerase II transcription (35). Thus, acetylation-
based tuning of protein–protein interactions may serve a gen-
eral role in transcriptional regulation as part of the complex
epigenetic regulatory network (38).
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